3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
14
NETWORK
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Fatigue
1
Interventions
Modafinil
2
reparixin
1
clazakizumab
1
Walking
1
Sodium Chloride
1
Saline Solution
1
Methylphenidate
1
Lenalidomide
1
EOM613
1
Darbepoetin alfa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Fatigue
×
Methylphenidate
×
Clear all
NCT00758407
2010-01-13
EMF
Medice Arzneimittel Pütter GmbH & Co KG
Phase 2/3
Completed
66 enrolled